UNH 2X Long ETF

CRWV rebound, TSM earnings, PPI reaction

October 15, 2026

The tape rotated hard out of the AI complex into the rest of the market. The S&P 500 closed +0.33% at 7,744, the Dow jumped +1.08% to 52,178, the Nasdaq managed only +0.08% to 26,713, and the Russell 2000 rose ~1.3–1.4%. Breadth was solid (roughly 7 of 10 S&P names higher) after an early dip. The 10-year yield fell ~9–10 bp to ~5.08–5.10% even as September PPI printed hot at +1.3% m/m and +6.3% y/y (well above consensus). Stocks absorbed the inflation print via lower yields and a defensive/broad rotation; tech (especially chips and AI infrastructure) lagged after the prior session’s funding scare.

AI Infrastructure Funding Scare Meets Huang’s Pushback

The dominant catalyst remained the re-pricing of AI financing risk, centered on $Coreweave(CRWV.US). Bond yields on its notes spiked toward 15% earlier in the week, CDS widened sharply, and the stock dropped ~15% Wednesday amid Gartner commentary on neocloud longevity and broader worries about leveraged data-center build-outs. Elon Musk’s “yikes” reply to a bond-yield chart added to the noise.

Today $Coreweave(CRWV.US) rebounded ~6% (closing near $69.70) after Nvidia CEO Jensen Huang, speaking in Stockholm, said CoreWeave’s strength is “improving every day,” its cost of capital is decreasing, and he does not see a need for Nvidia to provide a bailout. Nvidia already holds ~10% of the company and has a multi-year capacity purchase commitment. The comments helped stabilize parts of the AI complex (some neocloud and related names pared losses), but credit-market stress had not fully disappeared and the broader semiconductor bid stayed selective. For swing traders, this is a classic sentiment-reset catalyst: the fundamental backlog ($100B+ contracted) and Huang’s endorsement matter more than the overnight bond panic, but elevated funding costs remain a live risk if utilization or pricing disappoints. Watch whether the rebound holds into the next earnings window and whether peers ($Oracle(ORCL.US), $Nebius(NBIS.US), etc.) follow.

$Taiwan Semiconductor(TSM.US) Crushes Numbers, Stock Still Soft

Taiwan Semiconductor reported another record quarter: profit up ~69% y/y, revenue well above guidance, and Q4 revenue outlook of $52.3–54.3B (strong sequential growth). Management reiterated extremely robust demand for leading-edge AI and HPC chips. The U.S.-listed shares still finished lower as the broader AI sell-off overshadowed the beat. The print reinforces the “picks-and-shovels” case for the foundry and its key customers ($NVIDIA(NVDA.US), $AMD(AMD.US), $Broadcom(AVGO.US)), but the market is currently more focused on the financing side of the build-out than on end-demand confirmation. Near-term, the reaction shows how quickly good fundamental news can be discounted when the narrative is about capital intensity and credit.

Other Catalysts and Earnings

$Ericsson(ERIC.US) rose after a solid Q3 beat: organic sales +7%, adjusted EBITA ahead of consensus, Networks strength and cost discipline. Management noted higher component costs will pressure margins next year, but the print was clean enough to drive a clear positive reaction.

Healthcare led sectors (XLV ~+1.8–2%), helped by rotation into defensives and specific catalysts such as $Moderna(MRNA.US) (+4–5% after a Goldman target raise tied to Phase 3 melanoma data optimism). $Eli Lilly(LLY.US), $Unitedhealth(UNH.US) and other large-caps participated.

Analyst activity included upgrades on names such as $Bank of America(BAC.US) (to Outperform) and $Crocs(CROX.US), plus various initiations/resumptions, but nothing that redefined the tape the way the AI credit story and $Taiwan Semiconductor(TSM.US) print did.

Energy lagged (~-1.5%) despite some oil firmness; real estate and rate-sensitive areas benefited from the yield decline.

Healthcare, materials, consumer discretionary and financials led; technology and energy lagged. Equal-weight participation was healthier than the Nasdaq close implies—classic rotation rather than a broad risk-off day.

Notable Movers

Gainers: $Coreweave(CRWV.US) (rebound on Huang), $Ericsson(ERIC.US) (earnings), healthcare names, some Brazil-linked or other idiosyncratic moves from prior sessions continuing in pockets.

Decliners: Select AI/chip and infrastructure names that remained under pressure from the funding narrative; certain industrial or rate-sensitive names that did not fully participate in the Dow strength.

What Matters Next

Whether the $Coreweave(CRWV.US) rebound and Huang’s comments stabilize the AI financing narrative or if bond/CDS stress re-emerges (key for $NVIDIA(NVDA.US) and the broader complex).

More earnings (banks and others still reporting) and whether estimate revisions follow the $Taiwan Semiconductor(TSM.US) beat or stay muted by capital-cost worries.

Bond-market behavior with the 10-year near 5.1% after the hot PPI; a sustained yield drop would support the rotation, while a re-test of recent highs would pressure rate-sensitive and leveraged names.

FinTwit narratives around “AI overbuild vs. real demand” remain live—watch for continued debate on utilization, power, and funding costs versus pure semiconductor strength.

NFA / DYOR. This is market commentary based on public information and is not investment advice.

Rep. Kevin Hern (R) just disclosed 18 new stock trades

Every single one was a sell

Buys: $0

Sells: up to ~$945K

Including $Lockheed Martin(LMT.US), $Unitedhealth(UNH.US), $Chevron(CVX.US), $Devon Energy(DVN.US), & more

$Unitedhealth(UNH.US) | Bernstein SocGen Group 𝗿𝗲𝗶𝘁𝗲𝗿𝗮𝘁𝗲𝘀 𝗢𝘂𝘁𝗽𝗲𝗿𝗳𝗼𝗿𝗺 on 𝗨𝗻𝗶𝘁𝗲𝗱𝗛𝗲𝗮𝗹𝘁𝗵 𝗚𝗿𝗼𝘂𝗽, PT $𝟱𝟭𝟮

Analyst sees a continuing MA turnaround, with a solid quarterly beat and guidance raise driven by UHC and Optum Health.

$Unitedhealth(UNH.US) beat on earnings and raised its 2026 outlook for the third time this year

Q3 adjusted EPS came in at $4.69 vs $4.14 expected, up from $2.92 a year ago. Revenue was $112.69 billion vs $111.40 billion expected, per CNBC

The medical care ratio improved to 88.4% from 89.9% a year ago and came in better than estimates. That number got help from $610 million of favorable reserve development tied to earlier in 2026

$Unitedhealth(UNH.US) now expects 2026 adjusted EPS of at least $20.50, up from $19.50 to $20.00. Earnings from operations rose to $6.6 billion from $4.3 billion, led by improvement at Optum Health

Membership fell to about 48.3 million people from roughly 50.1 million a year ago, per Forbes

This is the quarter $Unitedhealth(UNH.US) bulls have been waiting for after a brutal stretch. Nearly half of the MCR improvement came from the reserve release though, so the margin story is more about pricing and benefit cuts than medical costs actually cooling

Source: StockMarket.News

$Unitedhealth(UNH.US) | Bernstein SocGen Group 𝗿𝗲𝗶𝘁𝗲𝗿𝗮𝘁𝗲𝘀 𝗢𝘂𝘁𝗽𝗲𝗿𝗳𝗼𝗿𝗺 on 𝗨𝗻𝗶𝘁𝗲𝗱𝗛𝗲𝗮𝗹𝘁𝗵 𝗚𝗿𝗼𝘂𝗽, maintains PT at $𝟱𝟭𝟮

Analyst sees Optum Insight and AI as significant long-term growth opportunities for UnitedHealth Group.

Here's a conveniently timed Trump trade

On 1/26, the government proposed paying UnitedHealth less per Medicare patient starting 2027

$Unitedhealth(UNH.US) dropped 20% next day

Here's where it gets convenient

Starting 2/23, Trump's portfolio bought $Unitedhealth(UNH.US) for four straight weeks, up to ~$345K

On 4/6, the government announced a 2.48% payment increase instead

The stock is up 42% since his February buy

White House says there's no conflict of interest

Here is every top $SPY performer (RP>85) currently sitting near the 50 day SMA 👀

$Unitedhealth(UNH.US)

$Datadog(DDOG.US)

$GE Vernova(GEV.US)

$Analog Devices(ADI.US)

$Lumentum(LITE.US)

$FedEx(FDX.US)

$Centene(CNC.US)

$Keysight Tech(KEYS.US)

$F5(FFIV.US)

$Moderna(MRNA.US)

$Casey General Stores(CASY.US)

$Teradyne(TER.US)

$Humana(HUM.US)

$Cisco(CSCO.US)

$Targa Resources(TRGP.US)